{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:55:39Z","timestamp":1791348939385,"version":"4.3.1"},"reference-count":22,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1994,5]]},"abstract":"<jats:p>Colorectal carcinoma in humans and animal models is associated with increased synthesis of prostaglandin E2 (PGE2). PGE2 synthesis was measured in normal and neoplastic human colorectal mucosa to investigate its role in the adenoma-carcinoma sequence. Paired mucosal biopsy specimens for PGE2 synthesis and histological examination were obtained during 39 diagnostic colonoscopies. Twelve control patients in whom colonoscopies and histology were normal synthesised similar amounts of PGE2 at all sites. Their results were (mean (SD) pg PGE2\/mg tissue) caecum 102.8 (15.9) (n = 6), ascending colon 110.8 (24.3) (n = 10), transverse colon 103.9 (19.5) (n = 11), descending colon 102.9 (23.2) (n = 12), sigmoid colon 96.4 (18.0) (n = 12), and rectum 107.1 (17.6) (n = 12). Nineteen patients had a total of 27 adenomatous polyps (rectum (1), sigmoid (22), descending (1), transverse (1), and ascending colon (1): histology-tubular (16), tubulo-villous (8), and villous adenomous (3)). The polyps (178.0 (55.0), n = 27) synthesised more PGE2 than controls (p &lt; 0.001), but the values in polyp-associated mucosa (mean (SD) 115.4 (21.9), n = 15) were not different to control results. Eight patients had carcinomas (rectal (2), sigmoid (4), and caecal (2)) all of which were adenocarcinomas. The cancers (193.6 (40.2), n = 8) synthesised more PGE2 than control specimens (p &lt; 0.001), but were not different to polyps. Cancer-associated mucosa (140.3 (27.7) n = 8) synthesised more PGE2 than control and polyp-associated mucosa. Colorectal neoplasia is associated with a progressive increase in PGE2 synthesis which may have a role in tumourigenesis and be a pathophysiological explanation for the beneficial effects of NSAIDs in animal models and human disease.<\/jats:p>","DOI":"10.1136\/gut.35.5.675","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"675-678","source":"Crossref","is-referenced-by-count":209,"title":["Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2."],"prefix":"10.1136","volume":"35","author":[{"given":"S","family":"Pugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1994,5,1]]},"reference":[{"key":"ref_1","first-page":"90","article-title":"Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal an neoplastic cultured tissue","volume":"22","author":"Jaffe, B.M.; Parker, C.W.; Philpott, G.W.","year":"1971","unstructured":"Jaffe BM, Parker CW, Philpott GW. Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal an neoplastic cultured tissue. Surgical Forum 1971;22:90-2.","journal-title":"Surgical Forum"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/bjc.1977.132","article-title":"Prostaglandins from tumours of human large bowel","volume":"35","author":"Bennett, A.; Del Tacca, M.; Stamford, I.F.; Zebro, T.","year":"1977","unstructured":"Bennett A, Del Tacca M, Stamford IF, Zebro T. Prostaglandins from tumours of human large bowel. Brj Cancer 1977; 35:881-4.","journal-title":"Brj Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0090-6980(81)90240-9","article-title":"Prostaglandins and cancer: a review of tumour initiation through tumour metastasis","volume":"21","author":"Honn, K.V.; Bockmann, R.S.; Marnett, L.J.","year":"1981","unstructured":"Honn KV, Bockmann RS, Marnett LJ. Prostaglandins and cancer: a review of tumour initiation through tumour metastasis. Prostaglandins 1981; 21: 833-64.","journal-title":"Prostaglandins"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0090-6980(74)80055-9","article-title":"Prostaglandins and cancer: an update","volume":"6","author":"Jaffe, B.M.","year":"1974","unstructured":"Jaffe BM. Prostaglandins and cancer: an update. Prostaglandins 1974; 6: 453-61.","journal-title":"Prostaglandins"},{"key":"ref_5","first-page":"592","article-title":"Investigation of endogenous prostaglandins in DMH-induced colonic cancer in rats","volume":"82","author":"Tanka, M.; Nazkazawa, S.; Koike, M.","year":"1985","unstructured":"Tanka M, Nazkazawa S, Koike M. Investigation of endogenous prostaglandins in DMH-induced colonic cancer in rats. ] Gastroenterol 1985; 82: 592-8."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF02049897","article-title":"Investigation of colonic prostaglandins in carcinogenesis in the rat colon","volume":"34","author":"Yamaguchi, A.; Ishida, T.; Nishimura, G.; Katoh, M.; Miyazaki, I.","year":"1991","unstructured":"Yamaguchi A, Ishida T, Nishimura G, Katoh M, Miyazaki I. Investigation of colonic prostaglandins in carcinogenesis in the rat colon. Dis Colon Rectum 1991; 34: 572-6.","journal-title":"Dis Colon Rectum"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02553001","article-title":"Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer","volume":"27","author":"Metzger, U.; Meier, J.; Uhlschmid, G.; Weihe, H.","year":"1984","unstructured":"Metzger U, Meier J, Uhlschmid G, Weihe H. Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis Colon Rectum 1984; 27: 366-9.","journal-title":"Dis Colon Rectum"},{"key":"ref_8","first-page":"5340","article-title":"Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a non-steroidal anti-inflammatory drug, during different stages of rat colon tumour development","volume":"47","author":"Reddy, B.S.; Maruyama, H.; Kelloff, G.","year":"1987","unstructured":"Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a non-steroidal anti-inflammatory drug, during different stages of rat colon tumour development. Cancer Res 1987; 47: 5340-7.","journal-title":"Cancer Res"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/carcin\/13.4.541","article-title":"Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis","volume":"13","year":"1992","unstructured":"Craven PA, DeRubertis FR. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis 1992; 13: 541-6.","journal-title":"Carcinogenesis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/gut.30.2.161","article-title":"Duodenal and antral mucosal prostaglandin E2 synthesis in a study of duodenal ulcer disease treated by H2 receptor antagonists","volume":"30","author":"Pugh, S.; Williams, S.E.; Lewin, M.R.; Ishaque, M.; Barton, T.P.; Bose, K.","year":"1989","unstructured":"Pugh S, Williams SE, Lewin MR, Ishaque M, Barton TP, Bose K, et al. Duodenal and antral mucosal prostaglandin E2 synthesis in a study of duodenal ulcer disease treated by H2 receptor antagonists. Gut 1989; 30: 161-5.","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/BF02051919","article-title":"Relationship between blood plasma prostaglandin E2 and liver lung metastases in colorectal cancer","volume":"33","author":"Narisawa, T.; Kusaka, H.; Yamazaki, Y.; Takahashi, M.; Koyama, H.; Koyama, K.","year":"1990","unstructured":"Narisawa T, Kusaka H, Yamazaki Y, Takahashi M, Koyama H, Koyama K et al. Relationship between blood plasma prostaglandin E2 and liver lung metastases in colorectal cancer. Dis Colon Rectum 1990; 33: 840-5.","journal-title":"Dis Colon Rectum"},{"key":"ref_12","first-page":"322","volume":"33","author":"Prostaglandins, Karmali K.; cancer","year":"1983","unstructured":"Karmali K. Prostaglandins and cancer. CA 1983; 33: 322-2.","journal-title":"CA"},{"key":"ref_13","first-page":"71","article-title":"Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients","volume":"95","author":"Balch, C.M.; Dougherty, P.A.; Cloud, G.A.; Tilden, A.B.","year":"1984","unstructured":"Balch CM, Dougherty PA, Cloud GA, Tilden AB. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgetv 1984; 95: 71-7.","journal-title":"Surgetv"},{"issue":"10","key":"ref_14","first-page":"363","article-title":"Prostaglandin E2 changes precede tumour formation in the dimethylhydrazine colon cancer model in rats","volume":"31","author":"Pugh, S.; Gellister, J.S.K.; Williams, S.E.; Lewin, M.R.; Barton, T.P.; Clark, C.G.","year":"1986","unstructured":"Pugh S, Gellister JSK, Williams SE, Lewin MR, Barton TP, Clark CG, et al. Prostaglandin E2 changes precede tumour formation in the dimethylhydrazine colon cancer model in rats. DigDisSci 1986; 31(10): 363 (S).","journal-title":"DigDisSci"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/carcin\/4.10.1225","article-title":"Inhibition of initiation and promotion by N-methylnitrosurea-induced colon carcinogenesis in rats by the NSAID indomethacin","volume":"4","author":"Narisawa, T.; Satoh, M.; Sano, M.; Takahashi, T.","year":"1983","unstructured":"Narisawa T, Satoh M, Sano M, Takahashi T. Inhibition of initiation and promotion by N-methylnitrosurea-induced colon carcinogenesis in rats by the NSAID indomethacin. Carcinogenesis 1983; 4: 1225-7.","journal-title":"Carcinogenesis"},{"key":"ref_16","first-page":"6741","article-title":"Prevention and treatment of primary intestinal tumours in rats by piroxicam","volume":"49","author":"Pollard, M.; Luckert, P.","year":"1989","unstructured":"Pollard M, Luckert P. Prevention and treatment of primary intestinal tumours in rats by piroxicam. CancerRes 1989; 49: 6741-73.","journal-title":"CancerRes"},{"key":"ref_17","first-page":"528","article-title":"Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression","volume":"92","author":"Tilden, A.B.; Balch, C.M.","year":"1982","unstructured":"Tilden AB, Balch CM. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. Surgery 1982; 92: 528-32.","journal-title":"Surgery"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.2930240119","article-title":"Sulindac for polyposis of the colon","volume":"24","author":"Waddell, W.R.; Longhry, R.W.","year":"1983","unstructured":"Waddell WR, Longhry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983; 24: 83-7.","journal-title":"J Surg Oncol"},{"key":"ref_19","first-page":"635","article-title":"Sulindac causes regression of rectal polyps in familial polyposis coli","volume":"101","author":"Labayle, D.; Fischer, D.; Vielh, P.; Drouhin, F.; Pariente, A.; Bories, C.","year":"1991","unstructured":"Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial polyposis coli.J7 Gastroenterol 1991; 101: 635-9."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer","volume":"325","author":"Thun, M.J.; Namboodiri, M.M.; WH, Jr, Clark","year":"1991","unstructured":"Thun MJ, Namboodiri MM, Clark WH Jr. Aspirin use and reduced risk of fatal colon cancer. New Engl J Med 1991; 325: 1593-6.","journal-title":"New Engl J Med"},{"key":"ref_21","first-page":"4399","article-title":"Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne colorectal cancer study","volume":"48","author":"Kune, G.A.; Kune, S.; Watson, L.E.","year":"1988","unstructured":"Kune GA, Kune S, Watson LE. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne colorectal cancer study. Cancer Res 1988; 48: 4399-404.","journal-title":"Cancer Res"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0016-5085(92)90021-P","article-title":"Effect of w-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer","volume":"103","author":"Anti, M.; Marra, G.; Armelao, F.; Bartoli, G.M.; Ficarella, R.; Percesepe, A.","year":"1992","unstructured":"Anti M, Marra G, Armelao F, Bartoli GM, Ficarella R, Percesepe A, et al. Effect of w-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992; 103: 883-91.","journal-title":"Gastroenterology"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.35.5.675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:59:47Z","timestamp":1757271587000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.35.5.675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,5]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1994,5,1]]},"published-print":{"date-parts":[[1994,5]]}},"alternative-id":["10.1136\/gut.35.5.675"],"URL":"https:\/\/doi.org\/10.1136\/gut.35.5.675","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,5]]}}}